Boston BioForum 2012 – Meeting the Challenges Through Innovation
CABA(Chinese-American BioMedical Association) Annual Conference
Date: Saturday, April 7, 2012; 8:30 AM – 9:00 PM
Venue: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor; Cambridge, MA
CABA Website: http://www.cabaweb.org/
Newspaper Ad
[pdf-ppt-viewer href="https://bostonese.com/wp-content/uploads/2012/03/2012_BioForum_Ad.pdf" width="700" height="500"]
Program guide
[pdf-ppt-viewer href="https://bostonese.com/wp-content/uploads/2012/03/2012_BioForum4.pdf" width="700" height="800"]
Boston BioForum 2012 – CABA Annual Conference
Meeting the Challenges Through Innovation
展望生物医药行业前景:以创新迎接挑战
Date: Saturday, April 7, 2012; 8:30 AM – 9:00 PM
Venue: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor; Cambridge, MA
Conference Agenda
8:00-9:00 Registration
9:00-9:05 Opening Remarks
Morning Session I
9:05-9:40 Combination Strategies to Cure Hepatitis C
Ron Renaud
Idenix Pharmaceuticals – CEO
9:40-10:10 The Story of Tysabri
Alfred Sandrock, M.D., Ph.D.
Biogen Idec. – Sr. Vice President, Development Sciences, Chief Medical Officer
10:10-10:45 Keeping Innovation-The Business of Vertex from a Science Perspective
Mark Namchuk, Ph.D.
Vertex Pharmaceuticals – SVP, Research
10:45-10:55 Coffee Break and Vendor Show
Morning Session II
10:55-11:30 Met-ing our Neighbors: Putting R&D into BD
Detlev Biniszkiewicz, Ph.D.
AstraZeneca – VP, IMED Strategy for Oncology
11:30-12:30 Panel Discussion: Integrated Drug R&D Services
Chen Chen, Ph.D. Sundia MediTech – CEO
Jifeng Liu, Ph.D. Aberjona – President
George Shi, Ph.D. Anichem – CSO
Maxine Rojas WuXi Apptec – Director, Business Development
Larry Cai, MBA Shanghai Medicilon – Sr. Director, Business Development
Ming Qi, Ph.D. Accelachem – President
Derek Ren, Ph.D. Viva – VP, Discovery Biology
Hui Li, Ph.D. BioDuro/PPD – Head of Business Development
12:30-1:30 Lunch Break, Vendor Show and Career Fair
AFTERNOON Session I
1:30-2:05 Filling the Gap between Basic Research and Drug Discovery: the Broad Approach
Michael Foley, Ph.D.
The Broad Institute – Director of Chemical Biology
2:05-2:35 Translating the Cancer Genome into Impactful Drugs
Markus Warmuth, M.D.
H3 Biomedicine – CEO
2:35-3:05 Planning and Challenges for Development of Innovative Drugs: the ARIAD Experience
Daniel M. Bollag, Ph.D.
Ariad – SVP, Regulatory Affairs and Quality
3:05-3:15 Coffee Break and Vendor Show
Afternoon Session II
3:15-3:45 Solution to “Tough-to-Drug” Targets: Integrated Discovery Engine of Macrocycles, DNA-Programmed Chemistry, Affinity-Based Selections & Next Generation Sequencing
Steve Hale, Ph.D.
Ensemble Therapeutics – VP, Screening & Biochemistry
3:45-3:55 Career Opportunities – China Biotech Opportunities
3:55-4:10 Career Opportunities – Deqing Biopark Introduction
4:10-5:00 Panel Discussion: Career Development & Entrepreneurship
Frank Feist NobelGen – CEO
Gangfeng Xu, Ph.D. Abbott Laboratories – Div. VP, Corp. Licensing & Acquisitions
Lauren Celano Propelcareers – CEO
Lixin Shen, Ph.D. Howfond Biopharma – CEO
Joshua Zhang, MD, PhD Ariad – Sr. Director, Clinical Research
5:00-5:30 Celebration of Five Years of Community Service and Leadership
5:30-6:15 Cocktail Social Hour: Networking and Vendor Show
Evening Session
6:15-7:00 Dinner
7:00-7:45 Chemical Probes for Epigenetics
Mark Bunnage, Ph.D.
Pfizer – VP, Head of Chem., BioTherapeutics Research
7:45-8:30 Building an Innovative Biotech: Lessons and Secrets
Chiang Li, M.D.
Boston Biomedical – Founder and CEO
8:30-9:30 Social Networking